Aurinia Pharmaceuticals closes public offering raising gross proceeds of $20 million themarketsignal.com/Free-Report/AUP The company is expected to report its Q2 2020 results on August 11, 2020, after markets close followed by a conference call from the executive team to offer a business update and discuss the results.